课题基金 / 基金详情

Investigating the Role of the Histone Demethylase LSD1/KDMI in Neurodegeneration

Investigating the Role of the Histone Demethylase LSD1/KDMI in Neurodegeneration
研究组蛋白去甲基化酶 LSD1/KDMI 在神经退行性变中的作用
批准号:
9237320
负责人:
David John Katz
金额:
$39.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-03-01 至 2020-02-28

项目摘要

项目成果

David John Katz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Alzheimer's disease (AD) and the related Frontotemporal Dementia (FTD) together affect ~5.4 million Americans and result in nearly $200 billion annually in healthcare and long-term patient care costs. Yet despite this massive health problem, large gaps remain in our understanding of these diseases. We have uncovered a novel epigenetic mechanism in mice that functions in the maintenance of differentiated hippocampus neurons, and we have linked this mechanism to AD and FTD. We hypothesize that this epigenetic mechanism is inhibited by pathological protein aggregates in aging adults, resulting in inappropriate transcription (including reactivation of stem cell transcription) and neuronal cell death. In this proposal, we will investigate this new epigenetic pathway in our mouse model as well as in human patient's samples. In addition, because (unlike other dementia models) our mouse model exhibits massive hippocampus neuronal cell death, we will combine our mouse model with other mouse models to identify common mechanisms of neuronal cell death, as occur in neurodegeneration. This proposal is significant in that it mechanistically bridges the gap between pathological aggregates observed in AD and FTD cases and the neuronal cell death that underlies these dementias. Based on these studies, it may be possible to therapeutically target this new pathway in AD and FTD patients. These studies will also investigate common mechanisms of neuronal cell death that could serve as additional potential therapeutic targets. As a result, this proposal is directly responsive to the National Plan to Address Alzheimer's Disease priority; to investigate new pathways that can be targeted for treatment. In addition, this proposal is innovative because it links a novel epigeneti mechanism that is required to maintain differentiated cell fates to AD and FTD. As a result, these studies will also significantly impact our understanding of basic developmental biology and stem cell biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating How Defects in The Maternal Germline Reprogramming of Histone Methylation Contribute to Inherited Disease
  • 批准号:
    10592730
  • 项目类别:
  • 资助金额:
    $38.71万
  • 财政年份:
    2022
  • 负责人:
    David John Katz
  • 依托单位:
Investigating the Role of the Histone Demethylase LSD1/KDMI in Neurodegeneration
  • 批准号:
    9012124
  • 项目类别:
  • 资助金额:
    $33.88万
  • 财政年份:
    2015
  • 负责人:
    David John Katz
  • 依托单位:
海外基金